Here's Why Investors Continue to Hold Pediatrix Medical Stock

Key Takeaways Pediatrix Medical benefits from a favorable payer mix and higher neonatology patient acuity.MD 2026 EPS estimated at $2.18, up 6.9% year over year, with stable RCM collections aiding performance.Pediatrix Medical trades at 9.39X forward P/E, below its five-year mean and the industry average.Pediatrix Medical Group, Inc. (MD) is well-poised to grow on the back of a favorable payer mix and higher patient acuity in neonatology. Strategic acquisitions are expected to increase its capacity and volu ...